Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

Pescovitz, Mark D., Greenbaum, Carla J., Krause-Steinrauf, Heidi, Becker, Dorothy J., Gitelman, Stephen E., Goland, Robin, Gottlieb, Peter A., Marks, Jennifer B., McGee, Paula F., Moran, Antoinette M., Raskin, Philip, Rodriguez, Henry, Schatz, Desmond A., Wherrett, Diane, Wilson, Darrell M., Lachin, John M., Skyler, Jay S.·2009·New England Journal of Medicine
DOI 10.1056/nejmoa0904452

Cited by (1,000)

Items 701–800 of 1,000

  1. From biomarkers to a clue of biology: a computation-aided perspective of immune gene expression profiles in human type 1 diabetes
    Dongmei Han, Xiaodong Cai, Ji Wen, Norma Sue Kenyon, Zhibin Chen · 2012 · Frontiers in Immunology
  2. Improving Type 1 Diabetes After Treatment of Immune Thrombocytopenia With Rituximab: Killing Two Birds With One Stone
    Laura Quintana, Juan Antonio Paniagua, D Gil-Contreras, Víctor Jiménez‐Yuste, Antonio Torres, Francisco Velasco · 2010 · Diabetes Care
  3. Novel functions of B cells in transplantation
    Jeffrey L. Platt, Shoichiro Tsuji, Marília Cascalho · 2010 · Current Opinion in Organ Transplantation
  4. Multimeric Insulin Desensitizes Insulin-Specific B Cells
    Stephanie N. Johnson, J. Daniel Griffin, Chrys Hulbert, Brandon J. DeKosky, James W. Thomas, Cory J. Berkland · 2020 · ACS Applied Bio Materials
  5. Thymic B Cells as a New Player in the Type 1 Diabetes Response
    Richard B. Greaves, Dawei Chen, E. Allison Green · 2021 · Frontiers in Immunology
  6. Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D
    Anneli Björklund, Ingrid Kathrin Hals, Valdemar Grill, Johnny Ludvigsson · 2022 · Frontiers in Endocrinology
  7. Comparative analysis of the repertoire of insulin-reactive B cells in type 1 diabetes-prone and resistant mice
    Maureen Banach, Isaac T. W. Harley, Andrew Getahun, John C. Cambier · 2022 · Frontiers in Immunology
  8. Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic
    Hiroyuki Sano, Akihisa Imagawa · 2022 · Biology
  9. Selective Silencing of Disease-Associated B Lymphocytes from Hashimoto’s Thyroiditis Patients by Chimeric Protein Molecules
    Nikola Ralchev, Aleksandar Mishel Markovski, Inna Angelova Yankova, Iliyan Konstantinov Manoylov, Irini Atanas Doytchinova, Nikolina Mihaylova, Alexander Dimitrov Shinkov, Andrey Ivanov Tchorbanov · 2022 · International Journal of Molecular Sciences
  10. Type 1 diabetes in the pancreas: A histological perspective
    Pia Leete · 2023 · Diabetic Medicine
  11. Suppression of B-Cell Activation by Human Cord Blood-Derived Stem Cells (CB-SCs) through the Galectin-9-Dependent Mechanism
    Wei Hu, Xiang Hui Song, Haibo Yu, Sophia Fan, Andrew Shi, Jingyu Sun, Hongjun Wang, Laura Zhao, Yong L. Zhao · 2024 · International Journal of Molecular Sciences
  12. Efficacy of teplizumab for treatment of type 1 diabetes: A meta‐analysis of randomized controlled trials
    Ehsan Heidari, Arman Shafiee, Shahab Noorian, Mohammad Ali Rafiei, Mohammad Reza Abbasi, Mohammad Javad Amini, Omid Safari, Fatemeh Aghamahdi, Mahmood Bakhtiyari · 2024 · Diabetes/Metabolism Research and Reviews
  13. Dépistage et prise en charge du diabète de type 1 préclinique, stade 1–2. Prise de position d’experts français
    Roberto Mallone, Élise Bismuth, Charles Thivolet, Pierre‐Yves Benhamou, Nadine Hoffmeister, François Collet, Marc P Nicolino, Rachel Reynaud, Jacques Beltrand, Jacques Beltrand et al. · 2024 · Médecine des Maladies Métaboliques
  14. Immune biomarkers in immunotherapeutic trials for type 1 diabetes: Cui prodest?
    Slobodan Čulina, Roberto Mallone · 2012 · Diabetes & Metabolism
  15. B cells in MS: Why, where and how?
    N. Pikor, J. Gommerman · 2012 · Multiple Sclerosis and Related Disorders
  16. The prolonged and enhanced immune response in the non-obese diabetic mouse is dependent on genes in the Idd1/24, Idd12 and Idd18 regions
    Mia Sundström, Kristina Lejon · 2010 · Journal of Autoimmunity
  17. Autoimmune (Type 1) Diabetes
    Ida Lindbladh, Agnes Andersson Svärd, Åke Lernmark · 2019 · Elsevier eBooks
  18. No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study
    Steffen Ullitz Thorsen, Christian Bressen Pipper, Henrik Bindesbøl Mortensen, Flemming Pociot, Jesper Johannesen, Jannet Svensson · 2016 · International Journal of Endocrinology
  19. New era of therapy for endocrine autoimmune disorders
    Bergithe Eikeland Oftedal, Anette S. B. Wolff · 2020 · Scandinavian Journal of Immunology
  20. Tailoring biologic therapy for real-world rheumatoid arthritis patients
    C. Romano, S. Esposito, R. Ferrara, G. Cuomo · 2020 · Expert Opinion on Biological Therapy
  21. Newly-onset Autoimmune Diabetes Mellitus Triggered by COVID 19 Infection: A Case-based Review
    Gamze Akkuş · 2022 · Endocrine Metabolic & Immune Disorders - Drug Targets
  22. The IL-1βReceptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic Mice
    Helena Cucak, Gitte Hansen, Niels Vrang, Torben Skarsfeldt, Eva Steiness, Jacob Jelsing · 2016 · Journal of Diabetes Research
  23. Immunoglobulin M gene association with autoantibody reactivity and type 1 diabetes
    Inês Rolim, Nádia Duarte, Gabriela Barata, João Costa, Luís Gardete-Correia, José Manuel Boavida, Rui A. Duarte, João Filipe Raposo, Zulmira Peerally, Manuela Beirão Catarino et al. · 2017 · Immunogenetics
  24. It's Time to Consider Changing the Rules
    Mark A. Atkinson · 2011 · Diabetes
  25. Nano-based therapy for type 1 diabetes: from immuno-intervention to insulin delivery.
    Hui-Wen Pang, Zhuo Chen, Felicity Y. Han · 2025 · Acta Biomaterialia
  26. Altered glucose metabolism in B cells: Implications for the pathogenesis and treatment of autoimmune diseases
    Mengyu Zhu, Xiaolong Li, Kai Zhao, Zhiyan Huang, Ting Zhao · 2025 · Journal of Autoimmunity
  27. B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes
    Christopher Wilson, Blair T. Stocks, Alexander C. Falk, Daniel J. Moore · 2025 · Diabetes
  28. Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders
    Valeria Sordi, Paolo Monti, Vito Lampasona, Raffaella Melzi, Silvia Pellegrini, Bart Keymeulen, Pieter Gillard, Thomas Linn, Emanuele Bosi, Ludger Rose et al. · 2023 · Frontiers in Endocrinology
  29. Type 1 Diabetes Depends on CD4-Driven Expression of the Transcriptional Repressor Bcl6
    Dudley H. McNitt, Jonathan M. Williams, Joseph G. Santitoro, Jacob Kim, James W. Thomas, Rachel H. Bonami · 2024 · Diabetes
  30. Type 1 diabetes mellitus—a door opening to a real therapy?
    Lucienne Chatenoud · 2011 · Nature Reviews Endocrinology
  31. Therapies for Type 1 Diabetes: Is a Cure Possible?
    Neihenuo Chuzho, Neetu Mishra, Nikhil Tandon, Neeraj Kumar · 2022 · Current Diabetes Reviews
  32. Islet cells in human type 1 diabetes: from recent advances to novel therapies – a symposium-based roadmap for future research
    James Cantley, Decio Laks Eizirik, Esther Latres, Colin Mark Dayan, _ _ · 2023 · Journal of Endocrinology
  33. Prevention trumps treatment of antibody-mediated transplant rejection
    Stuart J. Knechtle, Jean Kwun, Neal N. Iwakoshi · 2010 · Journal of Clinical Investigation
  34. Induction of thyroid remission using rituximab in a patient with type 3 autoimmune polyglandular syndrome including Graves’ disease and type 1 diabetes mellitus: A case report
    Akira Kurozumi, Yosuke Okada, Tadashi Arao, Manabu Narisawa, Keiichi Torimoto, Sunao Yamamoto, Yoshiya Tanaka · 2014 · Endocrine Journal
  35. The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis
    Mustafa Tosur, Mario Alberto Cleves, Jay M. Sosenko, Ingrid M. Libman, David A. Baidal, Ashok Balasubramanyam, MARIA JOSE REDONDO, Type 1 Diabetes TrialNet Study Group, Carla J. Greenbaum, Mark Stuart Anderson et al. · 2020 · The Journal of Clinical Endocrinology & Metabolism
  36. World Diabetes Day: Perspectives on immunotherapy of Type 1 Diabetes
    Lucienne Chatenoud · 2015 · European Journal of Immunology
  37. Identifying the ‘Achilles heel’ of type 1 diabetes
    Manuela Battaglia, Jane Hoyt Buckner, Megan K. Levings, Sarah J. Richardson, Florence Susan Wong, Timothy I. M. Tree · 2020 · Clinical & Experimental Immunology
  38. Incorporating Type 1 Diabetes Prevention Into Clinical Practice
    Justin M. Gregory, Jessica Sparks Lilley, Amanda Ackermann Misfeldt, Daniela L. Buscariollo, William E. Russell, Daniel J. Moore · 2010 · Clinical Diabetes
  39. Immune Intervention in Children with Type 1 Diabetes
    for The Linköping Diabetes Immune Intervention study group, Johnny Ludvigsson · 2010 · Current Diabetes Reports
  40. Modulating immune response for the prevention and treatment of type 1 diabetes
    Dilrasbonu Vohidova, Prasi Desai, Alvaro Moreno Lozano, Omid Veiseh A · 2026 · Frontiers in Immunology
  41. Messenger RNA delivery to islet β cells using conjugated lipid nanoparticles
    Jacob R. Enriquez, Zhengjie Zhou, Jennifer B. Nelson, Fei Huang, Kayla T. Figatner, Advaita Chakraborty, Sarida Pratuangtham, Brian Xi, Sarah C. May, Matthew Tirrell et al. · 2026 · Cell Reports Medicine
  42. Narrative Review of Anti-CD3 Antibody and Anti-CD20 Antibody: Immunotherapeutic Strategies to Treat and Prevent Type 1 Diabetes
    Shivani M. Desai, Prajakta Kashalikar, Avinash Purushottam Sanap, Madhura Shekatkar, Ramesh Ramchandra Bhonde · 2022 · Recent Advances in Inflammation & Allergy Drug Discovery
  43. Productive Germinal Center Responses Depend on the Nature of Stimuli Received by Anti-Insulin B Cells in Type 1 Diabetes–Prone Mice
    Dudley H. McNitt, Bryan A. Joosse, James W. Thomas, Rachel H. Bonami · 2023 · ImmunoHorizons
  44. The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: a practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium
    Stephanie Jean Hanna, Rachel H. Bonami, Brian Corrie, Monica Westley, Amanda L. Posgai, Eline T. Luning Prak, Felix J. Breden, Aaron W. Michels, Todd M. Brusko, Erin E. Baschal et al. · 2024 · Diabetologia
  45. Effect of Verapamil on Blood Glucose in Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Shiqi Tu, Ruiqi Zhang, Qiyue Zheng, Jiaojiao Wang, Yun Chen, Xiaosi Li, Jieyu He, Zhaokai Zhou, Qiong Lu · 2025 · Cardiovascular Drugs and Therapy
  46. Folate receptor-mediated targeting strategies for potential management & treatment of rheumatoid arthritis
    Afifa Shafiq, Hassan Shah, Aslam Khan, Safiullah Khan, Faizan Akram, Mamuna Shafique, Faisal Sattar, Muhammad Farhan Hanif, Muhammad Saad Hashmat, Asadullah Madni · 2025 · Journal of Drug Delivery Science and Technology
  47. Targeting the BLyS family in autoimmunity: a tale of mouse and man
    Jean L. Scholz, Eline T. Luning Prak, Michael P. Cancro · 2011 · Clinical Investigation
  48. B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice
    Kun Chen, Qian Xue, Fangfang Liu, Ling Liu, Caiyong Yu, Ganlan Bian, Kun Zhang, Chao Fang, Jun Ho Song, Gong Ju et al. · 2019 · Molecular Immunology
  49. Residual β-Cell Function in Type 1 Diabetes Followed for 2 Years after 3C Study
    Kun Lin, Xiaoping Yang, Yixi Wu, Shuru Chen, Qiong Zeng · 2021 · Journal of Diabetes Research
  50. Transient B-cell depletion and regulatory T-cells mediation in combination with adenovirus mediated IGF-1 prevents and reverses autoimmune diabetes in NOD mice
    Shujun Ye, Saimei Hua, Meiyang Zhou · 2022 · Autoimmunity
  51. Heterogeneity of circulating CXCR5-PD-1hiTph cells in patients of type 2 and type 1 diabetes in Chinese population
    Zhangyao Su, Chenggong Ma, Ruiling Zhao, Yin Zheng Jiang, Yun Cai, Yong Gu, Tao Yang, Xinyu Xu · 2023 · Acta Diabetologica
  52. Immunomodulatory agents and cell therapy for patients with type 1 diabetes
    Melanie Rodacki, Karina Ribeiro Silva, Débora Batista Araújo, Joana Rodrigues Dantas, Maria Eduarda Nascimento Ramos, Lenita Zajdenverg, Leandra Santos Baptista · 2024 · Archives of Endocrinology and Metabolism
  53. How do immune cells shape type 1 diabetes? Insights from Mendelian randomization
    Yunfeng Yu, Xinyu Yang, Juan Deng, Jingyi Wu, Siyang Bai, Rong Yu · 2024 · Frontiers in Endocrinology
  54. Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic mice
    Tamara Alkhamis, Jerko Barbić, Tatjana Crnogorac‐Jurcevic, Roseanna Greenlaw, Mark Peakman, Stipo Jurčević · 2012 · Clinical & Experimental Immunology
  55. Perspective: Testing failures
    Thomas R Mandrup-Poulsen · 2012 · Nature
  56. The Juvenile Diabetes Research Foundation at Forty: Updates of Research in Type 1 Diabetes
    Concepcion R. Nierras, Mark A. Atkinson, Robert A. Goldstein · 2010 · Diabetes
  57. How Does B-Cell Tolerance Contribute to the Protective Effects of Diabetes Following Induced Mixed Chimerism in Autoimmune Diabetes?
    Florence Susan Wong · 2014 · Diabetes
  58. A critical analysis of the (near) legendary status of vitamin D
    Ashlee N. McMillan, Jason Hicks, Christopher Isabella, Gerald M. Higa · 2011 · Expert Review of Endocrinology & Metabolism
  59. Stacking the Deck: Studies of Patients with Multiple Autoimmune Diseases Propelled Our Understanding of Type 1 Diabetes as an Autoimmune Disease
    Jane Hoyt Buckner, Carla J. Greenbaum · 2017 · The Journal of Immunology
  60. Towards effective beta-cell replacement through understanding and targeting of the autoreactive immune response during onset of type 1 diabetes
    Gustaf Christoffersson · 2021 · Journal of Immunology and Regenerative Medicine
  61. Therapeutic Uses of Stem Cells in Endocrinology- Review Article
    Ensieh Nasli‐Esfahani, Ardeshir Ghavamzadeh, Bagher A. Larijani · 2014 · DOAJ (DOAJ: Directory of Open Access Journals)
  62. ‘25‐Hydroxyvitamin D, Autoantigenic and Total Antibody Concentrations: Results from a Danish Case–control Study of Newly Diagnosed Patients with Childhood Type 1 Diabetes and their Healthy Siblings’
    Steffen Ullitz Thorsen, Christian Bressen Pipper, Jesper Johannesen, Henrik Bindesbøl Mortensen, Flemming Pociot, Jannet Svensson · 2017 · Scandinavian Journal of Immunology
  63. Type 1 Diabetes Therapy Beyond T Cell Targeting: Monocytes, B Cells, and Innate Lymphocytes
    Florence Susan Wong, Wen Li · 2012 · The Review of Diabetic Studies
  64. Inverse vaccination with islet autoantigens to halt progression of autoimmune diabetes
    Simon A. Hinke · 2011 · Drug Development Research
  65. Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab
    László Dávid Hegedűs, Terry J. Smith, Raymond S. Douglas, Claus Henrik Nielsen · 2011 · The Journal of Clinical Endocrinology & Metabolism
  66. Type 1 Diabetes Mellitus
    Silvio E. Inzucchi, Robert S. Sherwin · 2012 · Goldman's Cecil Medicine
  67. Autoimmune Type 1 Diabetes
    Shehab Alshiekh, Helena Elding Larsson, Sten Anders Ivarsson, Åke Lernmark · 2016 · Wiley eBooks
  68. Rituximab for thyroid-associated ophthalmopathy
    Neda Minakaran, Rajni Jain, Jimmy M. Uddin, Daniel G. Ezra · 2011 · Cochrane Database of Systematic Reviews
  69. Systems Analysis of Immune Changes after B-cell Depletion in Autoimmune Multiple Sclerosis
    Jessica Wei, Jeonghyeon Moon, Yoshiaki Yasumizu, Le Zhang, Khadir Radassi, Nicholas Buitrago-Pocasangre, M. Elizabeth Deerhake, Nicholas Strauli, Alan Chan, Ann E. Herman et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Optimizing Type 1 Diabetes Screening in People With Family History: A German Perspective
    Thomas Danne, Thomas Michael Kapellen, Sebastian A. Widholz, Martin Wabitsch, Ralph Ziegler · 2025 · Journal of Diabetes Science and Technology
  71. The role of memory T cells in type 1 diabetes: Phenotypes, mechanisms, and therapeutic implications
    Pooria Fazeli, Shiva Abolhasani, Negin Karamali, Mahsa Hajivalili, Gholamreza Daryabor, Mohammad Panji, Maryam Karimian, Maryam Hosseini · 2025 · Autoimmunity Reviews
  72. Evaluation of proinsulin(F25D) as a targeting ligand for insulin-binding B cells in autoimmune diabetes
    Kyle D. Apley, Lindsay E Bass, Jaylyn King, Grant M. Downes, K Wang, Mason V Forchetti, Daniel J. Moore, Peggy L. Kendall, Rachel H. Bonami, Cory J. Berkland · 2025 · Drug Delivery and Translational Research
  73. Beyond inflammation: the multifaceted therapeutic potential of targeting the CXCL8-CXCR1/2 axis in type 1 diabetes
    Georgia Fousteri, Meghan Jones, Rubina Novelli, Serena Boccella, Laura Brandolini, Andrea Aramini, Paolo Pozzilli, Marcello Allegretti · 2025 · Frontiers in Immunology
  74. Application of monoclonal antibodies in diabetes: A bibliometric analysis from 2004–2024
    Rui Wei, Bochao Jia, Shuang Zheng, Xuexue Zhang, Miaoran Wang, Ning Sun, Rui Zhang, Qiuyan Li · 2025 · Human Vaccines & Immunotherapeutics
  75. Autoimmune diabetes and targets for immunomodulation
    Camillo Bechi Genzano, Tyla Young, Rachel H. Bonami, Raniero Chimienti, Leonardo M. R. Ferreira, Emily Kristen Sims, Rémi J. Creusot · 2025 · Seminars in Immunology
  76. Leveraging circulating microRNAs for personalized disease-modifying therapies in type 1 diabetes
    Giuseppina Emanuela Grieco, Francesco Dotta, Guido Sebastiani · 2025 · Personalized Medicine
  77. Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes
    Lucienne Chatenoud · 2013 · Diabetes
  78. Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production
    Viqar Showkat Banday, Radha Thyagarajan, Mia Sundström, Kristina Lejon · 2016 · Immunology
  79. Biomedical Data Commons (BMDC) prioritizes B-lymphocyte non-coding genetic variants in Type 1 Diabetes
    Samantha N. Piekos, Sadhana Gaddam, Pranav Bhardwaj, Prashanth Radhakrishnan, Ramanathan V. Guha, Anthony E. Oro · 2021 · PLoS Computational Biology
  80. Biomarker und Typ-1-Diabetes
    Marie‐Christine Simon, Minh Nguyet Pham, Nanette Cathrin Schloot · 2012 · Der Diabetologe
  81. Surviving stiff-person syndrome: a case report
    Sharmilee Gnanapavan, Angela Carmen Vincent, Gavin Giovannoni · 2011 · Journal of Neurology
  82. Autoimmunity
    Dwight H. Kono, Argyrios N. Theofilopoulos · 2016 · Elsevier eBooks
  83. Diabetes Mellitus
    Leslie J. Raffel, Mark O. Goodarzi · 2013 · Elsevier eBooks
  84. Encephalomyocarditis Virus
    Seiho Nagafuchi, Hironori Kurisaki, Hitoshi Katsuta · 2012 · Springer eBooks
  85. Dead or Alive?
    Carla J. Greenbaum · 2012 · Diabetes Care
  86. Glutamic acid decarboxylase immunotherapy for type 1 diabetes
    Johnny Ludvigsson · 2022 · Current Opinion in Endocrinology Diabetes and Obesity
  87. Arresting type 1 diabetes: are we there yet? Obstacles and opportunities
    Chantal Mathieu, Pieter-Jan Martens · 2022 · Metabolism and Target Organ Damage
  88. β-Cell Glucose Sensitivity to Assess Changes in β-Cell Function in Recent-Onset Stage 3 Type 1 Diabetes
    Stephen Eric Gitelman, Carmella Evans‐Molina, Annamaria Guolo, Andrea Mari, Ele Ferrannini · 2023 · Diabetes
  89. Molecular targeted therapy against B cells in multiple sclerosis
    Yusei Miyazaki, Masaaki Niino · 2014 · Clinical and Experimental Neuroimmunology
  90. Annexin-coated particles induce antigen-specific immunosuppression
    Corinna Link, Fatmire Bujupi, Peter H. Krammer, Heiko Weyd · 2020 · Autoimmunity
  91. How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
    Michael J. Haller, Laura M. Jacobsen, Amanda L. Posgai, Desmond Schatz · 2021 · Diabetes
  92. Prevention of type 1 diabetes: where we are and where we are going
    Giulio Frontino, Nuzio S. GUERCIO, Andrea SCARAMUZZA, Giuseppe D’ANNUNZIO, Sonia Toni, Felice CITRINITI, Riccardo Bonfanti · 2021 · Minerva Pediatrics
  93. Immune intervention therapy in type 1 diabetes: safety first
    Bart O. Roep · 2013 · The Lancet Diabetes & Endocrinology
  94. Update on Global Intervention Studies in Type 1 Diabetes
    Jane L. Chiang, Michael J. Haller, Desmond Schatz · 2012 · Endocrinology and Metabolism Clinics of North America
  95. Prediction and prevention of type 1 diabetes mellitus: initial results and recent prospects
    L Madácsy · 2011 · Orvosi Hetilap
  96. Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes
    Cristina Vazquez‐Mateo, Justin Collins, Sarah J. Goldberg, Maxx Lawson, Jaileene Hernandez Escalante, Hans Dooms · 2019 · PLoS ONE
  97. Rituximab, B-Lymphocyte Depletion, and Beta-Cell Function
    Seiho Nagafuchi, Hitoshi Katsuta, Keizo Anzai · 2010 · New England Journal of Medicine
  98. Historically Based Perspective on the Immunotherapy of Type 1 Diabetes: Where We Have Been, Where We Are, and Where We May Go
    Eugenio Cavalli, Giuseppe Rosario Pietro Nicoletti, Ferdinando Nicoletti · 2025 · Journal of Clinical Medicine
  99. The protective role of TIGIT + B cells in attenuating type 1 diabetes progression
    Yiman Peng, Jingyue Li, Ying Deng, Zhiguang Zhou, Mengyao Shu · 2025 · Diabetes Obesity and Metabolism
  100. Clinical parameters and emerging biomarkers of partial remission in pediatric type 1 diabetes: a systematic review
    Camille Dikranian, Oumayma Hadara, Philippe Antoine Lysy · 2026 · Frontiers in Endocrinology